Medical Practice Confirms Clinical Trial Results of the Use of Intralesional Human Recombinant Epidermal Growth Factor in Advanced Diabetic Foot Ulcers

Pedro A López-Saura^1*, Isis B Yera-Alos², Carmen Valenzuela-Silva², Odalys González-Díaz², Amaurys Del Río-Martín², Jorge Berlanga-Acosta³, José I Fernández-Montequín⁴, Boris Acevedo-Castro⁵, Ernesto López-Mola⁵ and Luis Herrera-Martínez⁶

¹Clinical Research Direction, Center for Genetic Engineering and Biotechnology, Havana (CIGB), Cuba

²Clinical Research Direction, CIGB, Cuba

³Biomedical Research Direction, CIGB, Cuba

⁴National Institute for Angiology and Vascular Surgery, Havana, Cuba

⁵Business and Projects Development Direction, CIGB, Cuba

⁶Luis Herrera-Martínez: General Direction, CIGB, Cuba

^*Corresponding Author: